Results 21 to 30 of about 260,112 (235)

Treatment quality and outcome for multidrug-resistant tuberculosis patients in four regions of China: a cohort study

open access: yesInfectious Diseases of Poverty, 2020
Background China incurs an extremely low treatment coverage of multidrug-resistant tuberculosis (MDR-TB). This study aimed to understand the experience of MDR-TB patients on quality of health care, and the clinical impact through an up to six-year follow-
Xu-Bin Zheng   +7 more
doaj   +1 more source

Adverse Events among HIV/MDR-TB Co-Infected Patients Receiving Antiretroviral and Second Line Anti-TB Treatment in Mumbai, India. [PDF]

open access: yes, 2012
Significant adverse events (AE) have been reported in patients receiving medications for multidrug- and extensively-drug-resistant tuberculosis (MDR-TB & XDR-TB).
Varghese, B   +51 more
core   +1 more source

Screening and identification of differentially expressed long non-coding RNAs in multidrug-resistant tuberculosis [PDF]

open access: yesPeerJ, 2022
Background Efforts to eradicate tuberculosis are largely threatened by drug-resistant tuberculosis, particularly, multidrug-resistant tuberculosis (MDR-TB).
Junwei Zhao   +6 more
doaj   +2 more sources

Multidrug-resistant Tuberculosis Burden among the New Tuberculosis Patients in Zhejiang Province: An Observational Study, 2009–2013

open access: yesChinese Medical Journal, 2017
Background: Screening on multidrug-resistant tuberculosis (MDR-TB) has been limited to the serious TB subpopulations excluding the new TB patients. This study aimed to examine MDR-TB burden among the new TB patients.
Ying Peng   +11 more
doaj   +1 more source

Rising challenge of multidrug-resistant tuberculosis in China: a predictive study using Markov modeling

open access: yesInfectious Diseases of Poverty, 2020
Background Multidrug-resistant tuberculosis (MDR-TB) is on the rise in China. This study used a dynamic Markov model to predict the longitudinal trends of MDR-TB in China by 2050 and to assess the effects of alternative control measures.
Bing-Ying Li   +8 more
doaj   +1 more source

Cost-effectiveness of bedaquiline in MDR and XDR tuberculosis in Italy

open access: yesJournal of Market Access & Health Policy, 2017
Objective: To evaluate the cost-effectiveness of bedaquiline plus background drug regimens (BR) for multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB) in Italy.
Luigi R. Codecasa   +9 more
doaj   +1 more source

Programmatically selected multidrug-resistant strains drive the emergence of extensively drug-resistant tuberculosis in South Africa [PDF]

open access: yes, 2013
South Africa shows one of the highest global burdens of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB). Since 2002, MDR-TB in South Africa has been treated by a standardized combination therapy, which until 2010 included
Pillay, Manormoney   +41 more
core   +2 more sources

MDR-TB TREATMENT UPDATE

open access: yesInternational Journal of Infectious Diseases, 2023
Rifampicin-resistant tuberculosis (RR-TB) accounts for an expanding proportion of incident global TB cases and is a major barrier to global tuberculosis control. Conventional therapy for RR-TB is more toxic, less effective, and much more costly than drug-susceptible TB.
openaire   +2 more sources

Evaluation of a standardized treatment regimen of anti-tuberculosis drugs for patients with multi-drug-resistant tuberculosis (STREAM) : study protocol for a randomized controlled trial [PDF]

open access: yes, 2014
Background In contrast to drug-sensitive tuberculosis, the guidelines for the treatment of multi-drug-resistant tuberculosis (MDR-TB) have a very poor evidence base; current recommendations, based on expert opinion, are that patients should be treated ...
Squire, Stephen Bertel   +25 more
core   +2 more sources

Comparison of the yield of tuberculosis among contacts of multidrug-resistant and drug-sensitive tuberculosis patients in Ethiopia using GeneXpert as a primary diagnostic test

open access: yesInternational Journal of Infectious Diseases, 2018
Objectives: This study compared the yield of tuberculosis (TB) among contacts of multidrug-resistant tuberculosis (MDR-TB) index cases with that in drug-sensitive TB (DS-TB) index cases in a program setting.
Nebiyu Hiruy   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy